"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,1,27,0,0,0,27,0,0,50.226244,3,0.127602,70.531812,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
1,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,1,54,0,0,0,55,0,0,49.773756,3.054545,0.127164,73.371643,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
1,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,3,39,0,0,5,35,0,0,13.071673,0.538462,0.138664,2.090952,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
1,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Storm 1990",NA,0,0,0,0,5,33,0,0,6,33,0,0,14.881597,0.833333,0.28178,2.464489,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
1,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,14,107,0,0,12,107,0,0,29.763194,1.166667,0.566185,2.404006,"Both etidronate 400 mg/day and placebo were used in ADFR regimen. ","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
1,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,20,105,0,0,16,104,0,0,39.874135,1.238095,0.680251,2.253402,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
1,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,2.409401,1.058824,0.071775,15.619811,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
1,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,2,27,0,0,3,27,0,0,33.538462,0.666667,0.12084,3.677963,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
1,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,3,54,0,0,6,55,0,0,66.461538,0.509259,0.13414,1.933387,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
1,7,"Serious adverse events","Serious adverse events, primary","SUBGROUP_AND_OVERALL","Adami 2000",NA,0,0,0,0,2,53,0,0,2,54,0,0,7.99159,1.018868,0.148929,6.970375,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
1,7,"Serious adverse events","Serious adverse events, primary","SUBGROUP_AND_OVERALL","Heath 2000",NA,0,0,0,0,3,38,0,0,1,39,0,0,3.981108,3.078947,0.334857,28.310306,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
1,7,"Serious adverse events","Serious adverse events, primary","SUBGROUP_AND_OVERALL","Herd 1997",NA,0,0,0,0,8,74,0,0,7,76,0,0,27.857978,1.173745,0.448274,3.073297,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
1,7,"Serious adverse events","Serious adverse events, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,2,27,0,0,6,27,0,0,24.200946,0.333333,0.073726,1.507072,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
1,7,"Serious adverse events","Serious adverse events, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,7,54,0,0,9,55,0,0,35.968378,0.792181,0.317733,1.975089,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
1,7,"Serious adverse events","Serious adverse events, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,0,50,0,0,0,50,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
2,1,"Radiographic vertebral fractures","Radiographic vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,1,49,0,0,6,46,0,0,100,0.156463,0.019578,1.250412,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
3,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,1,27,0,0,0,27,0,0,50.226244,3,0.127602,70.531812,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
3,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,1,54,0,0,0,55,0,0,49.773756,3.054545,0.127164,73.371643,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
3,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,20,105,0,0,16,104,0,0,57.259714,1.238095,0.680251,2.253402,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
3,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,14,107,0,0,12,107,0,0,42.740286,1.166667,0.566185,2.404006,"Both etidronate 400 mg/day and placebo were used in ADFR regimen. ","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
3,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,2,27,0,0,3,27,0,0,33.538462,0.666667,0.12084,3.677963,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
3,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,3,54,0,0,6,55,0,0,66.461538,0.509259,0.13414,1.933387,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
4,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Storm 1990",NA,0,0,0,0,5,33,0,0,6,33,0,0,100,0.833333,0.28178,2.464489,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
4,2,"Hip fractures","Hip Fractures, primary","SUBGROUP_AND_OVERALL","Montessori 1997",NA,0,0,0,0,0,40,0,0,0,40,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
5,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,3,50,0,0,5,50,0,0,83.732057,0.6,0.151456,2.376925,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
5,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,16.267943,1.058824,0.071775,15.619811,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
5,2,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,1,50,0,0,2,50,0,0,100,0.5,0.046823,5.339256,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
6,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,1,27,0,0,0,27,0,0,100,3,0.127602,70.531812,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
6,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,2,27,0,0,3,27,0,0,100,0.666667,0.12084,3.677963,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
6,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Storm 1990",NA,0,0,0,0,5,33,0,0,6,33,0,0,17.119387,0.833333,0.28178,2.464489,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
6,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,14,107,0,0,12,107,0,0,34.238774,1.166667,0.566185,2.404006,"Both etidronate 400 mg/day and placebo were used in ADFR regimen. ","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
6,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,20,105,0,0,16,104,0,0,45.870128,1.238095,0.680251,2.253402,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
6,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,2.77171,1.058824,0.071775,15.619811,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
7,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,1,27,0,0,0,27,0,0,50.226244,3,0.127602,70.531812,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
7,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,1,54,0,0,0,55,0,0,49.773756,3.054545,0.127164,73.371643,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
7,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,2,27,0,0,3,27,0,0,33.538462,0.666667,0.12084,3.677963,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
7,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,3,54,0,0,6,55,0,0,66.461538,0.509259,0.13414,1.933387,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
7,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,3,50,0,0,5,50,0,0,12.485023,0.6,0.151456,2.376925,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
7,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Storm 1990",NA,0,0,0,0,5,33,0,0,6,33,0,0,14.982028,0.833333,0.28178,2.464489,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
7,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,20,105,0,0,16,104,0,0,40.143232,1.238095,0.680251,2.253402,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
7,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,14,107,0,0,12,107,0,0,29.964055,1.166667,0.566185,2.404006,"Both etidronate 400 mg/day and placebo were used in ADFR regimen. ","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
7,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,2.425662,1.058824,0.071775,15.619811,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
8,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,3,50,0,0,5,50,0,0,12.485023,0.6,0.151456,2.376925,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
8,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Storm 1990",NA,0,0,0,0,5,33,0,0,6,33,0,0,14.982028,0.833333,0.28178,2.464489,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
8,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,20,105,0,0,16,104,0,0,40.143232,1.238095,0.680251,2.253402,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
8,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,14,107,0,0,12,107,0,0,29.964055,1.166667,0.566185,2.404006,"Both etidronate 400 mg/day and placebo were used in ADFR regimen. ","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
8,1,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,2.425662,1.058824,0.071775,15.619811,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
8,2,"Hip fractures","Hip fractures, primary","SUBGROUP_AND_OVERALL","Montessori 1997",NA,0,0,0,0,0,40,0,0,0,40,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
8,2,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,1,50,0,0,2,50,0,0,79.924242,0.5,0.046823,5.339256,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
8,2,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,1,105,0,0,0,104,0,0,20.075758,2.971698,0.122447,72.120924,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
9,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,1,27,0,0,0,27,0,0,100,3,0.127602,70.531812,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
9,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,2,27,0,0,3,27,0,0,100,0.666667,0.12084,3.677963,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
9,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Lyritis 1997",NA,0,0,0,0,3,50,0,0,5,50,0,0,12.485023,0.6,0.151456,2.376925,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
9,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Storm 1990",NA,0,0,0,0,5,33,0,0,6,33,0,0,14.982028,0.833333,0.28178,2.464489,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
9,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,20,105,0,0,16,104,0,0,40.143232,1.238095,0.680251,2.253402,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
9,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,14,107,0,0,12,107,0,0,29.964055,1.166667,0.566185,2.404006,"Both etidronate 400 mg/day and placebo were used in ADFR regimen.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
9,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,2.425662,1.058824,0.071775,15.619811,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
10,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,1,27,0,0,0,27,0,0,50.226244,3,0.127602,70.531812,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
10,1,"Clinical vertebral fractures","Clinical vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,1,54,0,0,0,55,0,0,49.773756,3.054545,0.127164,73.371643,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
10,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Meunier 1997",NA,0,0,0,0,2,27,0,0,3,27,0,0,33.538462,0.666667,0.12084,3.677963,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
10,2,"Non-vertebral fractures","Non-vertebral fractures, primary","SUBGROUP_AND_OVERALL","Pouilles 1997",NA,0,0,0,0,3,54,0,0,6,55,0,0,66.461538,0.509259,0.13414,1.933387,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
10,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Storm 1990",NA,0,0,0,0,5,33,0,0,6,33,0,0,26.032646,0.833333,0.28178,2.464489,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
10,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Watts 1990",1990,0,0,0,0,20,105,0,0,16,104,0,0,69.752545,1.238095,0.680251,2.253402,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
10,2,"Non-vertebral fractures","Non-vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,4.214809,1.058824,0.071775,15.619811,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
11,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,1,66,0,0,100,0.333333,0.013825,8.036802,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
11,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
11,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
11,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
11,7,"Atypical femoral fractures","Atypical femoral fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
11,7,"Atypical femoral fractures","Atypical femoral fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","7::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.10961174207013,0.00215247660905914,-0.715104108984887,0.495880624844627,-0.0430431465899993,0.0473480998081176,TRUE,TRUE
12,1,"Radiographic vertebral fractures","Radiographic vertebral fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,5,66,0,0,9,66,0,0,100,0.555556,0.196637,1.569605,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
13,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,1,66,0,0,100,0.333333,0.013825,8.036802,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
13,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
13,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
13,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
14,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
14,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
15,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,1,66,0,0,100,0.333333,0.013825,8.036802,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
15,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
15,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
15,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
16,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,1,66,0,0,100,0.333333,0.013825,8.036802,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
16,1,"Hip fractures","Hip fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
16,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
16,2,"Wrist fractures","Wrist fractures, secondary","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,24,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
17,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
17,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,18,0,0,4.699496,1.058824,0.071775,15.619811,"HRT: Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus etidronate 400 mg/day plus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,17,0,0,1,19,0,0,4.568955,1.117647,0.075604,16.522006,"HRT: Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus HRT","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,0,66,0,0,2.418858,3,0.124428,72.331217,"HRT: conjugated estrogen 0.625 mg/day plus medroxyprogesterone 2.5 mg/day","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 400 mg/day plus HRT versus placebo","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,19,0,0,1,18,0,0,4.968466,0.947368,0.063937,14.037464,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 400 mg/day plus HRT versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,19,0,0,1,18,0,0,4.968466,0.947368,0.063937,14.037464,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,0,25,0,0,0,25,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus fluoride 50 mg/day","SUBGROUP_AND_OVERALL","Guañabens 2000",NA,0,0,0,0,6,47,0,0,6,31,0,0,34.980412,0.659574,0.23389,1.860011,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,1,66,0,0,4.837717,1,0.063881,15.654039,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus risedronate 2.5 mg/day","SUBGROUP_AND_OVERALL","Fukunaga 2002",2002,0,0,0,0,4,117,0,0,7,118,0,0,33.719914,0.576313,0.173311,1.916421,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus calcitonin 20 IU/week, IV","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,0,66,0,0,2.418858,3,0.124428,72.331217,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
18,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,0,66,0,0,2.418858,3,0.124428,72.331217,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus calcitonin 20 IU/week, IV","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus HRT","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"HRT: conjugated estrogen 0.625 mg/day plus medroxyprogesterone 2.5 mg/day","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,23,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,0,25,0,0,0,25,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus etidronate 200 mg/day plus alfacalcidol 1 μg/day)","SUBGROUP_AND_OVERALL","Iwamoto 2003b",2003,0,0,0,0,0,20,0,0,0,20,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
19,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus HRT","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"HRT: conjugated estrogen 0.625 mg/day plus medroxyprogesterone 2.5 mg/day","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus calcitonin 20 IU/week, IV","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,0,25,0,0,0,25,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus etidronate 200 mg/day plus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Iwamoto 2003b",2003,0,0,0,0,0,20,0,0,0,20,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
20,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,23,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus fluoride 50 mg/day","SUBGROUP_AND_OVERALL","Guañabens 2000",NA,0,0,0,0,8,47,0,0,5,31,0,0,11.016315,1.055319,0.380091,2.930082,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,3,17,0,0,2,18,0,0,3.552008,1.588235,0.301419,8.368711,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,0,25,0,0,0,25,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus risedronate 2.5 mg/day","SUBGROUP_AND_OVERALL","Fukunaga 2002",2002,0,0,0,0,2,106,0,0,0,101,0,0,0.935989,4.766355,0.231623,98.082321,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,8,66,0,0,11,66,0,0,20.110635,0.727273,0.312595,1.692046,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus calcitonin 20 IU/week, IV","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,8,66,0,0,8,66,0,0,14.625917,1,0.399049,2.505958,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus HRT","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,8,66,0,0,7,66,0,0,12.797677,1.142857,0.439663,2.970732,"HRT: conjugated estrogen 0.625 mg/day plus medroxyprogesterone 2.5 mg/day","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,8,66,0,0,9,66,0,0,16.454156,0.888889,0.365335,2.16274,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,2,25,0,0,2,23,0,0,3.808832,0.92,0.140893,6.007404,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 400 mg/day plus HRT versus placebo","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,19,0,0,5,18,0,0,9.388257,0.189474,0.024442,1.468818,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 400 mg/day plus HRT versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,1,19,0,0,2,18,0,0,3.755303,0.473684,0.046912,4.78294,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus etidronate 200 mg/day plus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Iwamoto 2003b",2003,0,0,0,0,1,20,0,0,1,20,0,0,1.82824,1,0.067096,14.903915,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
21,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus etidronate 400 mg/day plus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,3,17,0,0,1,19,0,0,1.726671,3.352941,0.384167,29.2639,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
22,1,"Treatment versus reference, primary","Etidronate 400 mg/day versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1995",NA,0,0,0,0,2,14,0,0,2,15,0,0,21.538462,1.071429,0.173667,6.610111,"HRT: [17B-E2 2.5 g/day (percutaneous Oestrogel)] + 12-day micronized progesterone 200 mg/day each month + 1 g/day elemental calcium supplements","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
22,1,"Treatment versus reference, primary","Etidronate 400 mg/day versus etidronate 400 mg/day plus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1995",NA,0,0,0,0,2,14,0,0,2,15,0,0,21.538462,1.071429,0.173667,6.610111,"HRT: [17B-E2 2.5 g/day (percutaneous Oestrogel)] + 12-day micronized progesterone 200 mg/day each month + 1 g/day elemental calcium supplements","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
22,1,"Treatment versus reference, primary","Etidronate 400 mg/day plus HRT versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1995",NA,0,0,0,0,2,15,0,0,2,15,0,0,22.307692,1,0.161278,6.200483,"HRT: [17B-E2 2.5 g/day (percutaneous Oestrogel)] + 12-day micronized progesterone 200 mg/day each month + 1 g/day elemental calcium supplements","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
22,1,"Treatment versus reference, primary","Etidronate 400 mg/day plus HRT versus placebo","SUBGROUP_AND_OVERALL","Wimalawansa 1995",NA,0,0,0,0,2,15,0,0,3,14,0,0,34.615385,0.622222,0.121396,3.189226,"HRT: [17B-E2 2.5 g/day (percutaneous Oestrogel)] + 12-day micronized progesterone 200 mg/day each month + 1 g/day elemental calcium supplements","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 10 mg/day","SUBGROUP_AND_OVERALL","Köşüş 2005",2005,0,0,0,0,0,22,0,0,3,24,0,0,5.99642,0.15528,0.008471,2.846371,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 10 mg/day","SUBGROUP_AND_OVERALL","Sahota 2000",2000,0,0,0,0,0,36,0,0,6,37,0,0,11.465453,0.079002,0.004613,1.35299,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,3,17,0,0,3,18,0,0,5.210022,1.058824,0.246743,4.54363,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus etidronate 400 mg/day + HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,3,17,0,0,4,19,0,0,6.753732,0.838235,0.218096,3.221701,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,0,66,0,0,0.893876,3,0.124428,72.331217,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 200 mg/day versus calcitonin 20 IU/week, IV","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,0,66,0,0,0.893876,3,0.124428,72.331217,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 200 mg/day versus HRT","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,3,66,0,0,5.363257,0.333333,0.035582,3.122686,"HRT: conjugated estrogen 0.625 mg/day plus medroxyprogesterone 2.5 mg/day","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,1,66,0,0,0,66,0,0,0.893876,3,0.124428,72.331217,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day + calcitriol 0.5 μg/day versus calcitriol 0.5 μg/day","SUBGROUP_AND_OVERALL","Gürlek 1997",NA,0,0,0,0,0,10,0,0,0,10,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day + HRT versus placebo","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,4,19,0,0,3,18,0,0,5.50821,1.263158,0.327128,4.877509,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day + HRT versus HRT","SUBGROUP_AND_OVERALL","Wimalawansa 1998",NA,0,0,0,0,4,19,0,0,3,18,0,0,5.50821,1.263158,0.327128,4.877509,"HRT: [Premarin 0.625 mg/day + norgestrel 150 μg/day] for 12 days per month","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus calcitriol 0.5 μg/day","SUBGROUP_AND_OVERALL","Sahota 2000",2000,0,0,0,0,0,36,0,0,1,34,0,0,2.756118,0.315315,0.013283,7.484876,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus fluoride 50 mg/day","SUBGROUP_AND_OVERALL","Guañabens 2000",NA,0,0,0,0,3,63,0,0,13,55,0,0,24.816429,0.201465,0.06055,0.670327,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 200 mg/day versus etidronate 200 mg/day + alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,0,20,0,0,0,20,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day + calcitriol 0.5 μg/day versus calcitonin 100 IU/2 days, IN + calcitriol 0.25 μg/day","SUBGROUP_AND_OVERALL","Gürlek 1997",NA,0,0,0,0,0,10,0,0,0,10,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus etidronate 400 mg/day + calcitriol 0.5 μg/day","SUBGROUP_AND_OVERALL","Masud 1998",1998,0,0,0,0,5,28,0,0,4,30,0,0,6.904423,1.339286,0.399485,4.489999,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic alendronate 10 mg/day","SUBGROUP_AND_OVERALL","Köşüş 2005",2005,0,0,0,0,0,22,0,0,0,24,0,0,NA,NA,NA,NA,"intermittent/cyclic Alendronate: Alendronate 10 mg/day for 14 days, followed by 76 days of calcium tablets for 1 year.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic alendronate 10 mg/day","SUBGROUP_AND_OVERALL","Sahota 2000",2000,0,0,0,0,0,36,0,0,1,33,0,0,2.794937,0.306306,0.01291,7.267318,"intermittent/cyclic Alendronate: Alendronate 10 mg once daily in 3-monthly cycles on/off for 60 weeks.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,0,25,0,0,0,25,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
22,2,"Treatment versus reference, secondary","Etidronate 200 mg/day versus risedronate 2.5 mg/day","SUBGROUP_AND_OVERALL","Fukunaga 2002",2002,0,0,0,0,7,117,0,0,8,118,0,0,14.24116,0.882479,0.330668,2.355134,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","2::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.031418176542453,9.18372969363503e-05,-0.204630908291632,0.141794555206726,-0.00965758445802354,0.00984125905189624,TRUE,TRUE
23,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus ADFR","SUBGROUP_AND_OVERALL","Steiniche 1991",NA,0,0,0,0,0,19,0,0,0,18,0,0,NA,NA,NA,NA,"ADFR: four repeated cycle of (7 day triiodothyronine 100 μg/day → 2-week etidronate 400 mg/day→ 12-week drug-free). ","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
23,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,0,25,0,0,0,25,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
23,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
23,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
24,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus fluoride 50 mg/day","SUBGROUP_AND_OVERALL","Guañabens 2000",NA,0,0,0,0,10,47,0,0,12,31,0,0,33.337291,0.549645,0.271278,1.113653,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
24,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2005",2005,0,0,0,0,2,25,0,0,1,25,0,0,2.305238,2,0.193511,20.670629,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
24,1,"Treatment versus reference, secondary","Etidronate 200 mg/d versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,5,25,0,0,0,23,0,0,1.198724,10.153846,0.592415,174.034375,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
24,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus ADFR","SUBGROUP_AND_OVERALL","Steiniche 1991",NA,0,0,0,0,2,19,0,0,0,18,0,0,1.182173,4.75,0.243513,92.654378,"ADFR: four repeated cycle of (7 day triiodothyronine 100 μg/day → 2-week etidronate 400 mg/day→ 12-week drug-free). ","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
24,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus etidronate 200 mg/day + alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Iwamoto 2003b",2003,0,0,0,0,0,20,0,0,0,20,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
24,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus risedronate 2.5 mg/day","SUBGROUP_AND_OVERALL","Fukunaga 2002",2002,0,0,0,0,23,117,0,0,27,118,0,0,61.976574,0.859133,0.524294,1.407815,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
25,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus alendronate 5 mg/day","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,38,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
25,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus alfacalcidol 1 μg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
25,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
25,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus menatetrenone 45 mg/day","SUBGROUP_AND_OVERALL","Iwamoto 2001",NA,0,0,0,0,0,25,0,0,0,23,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
25,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus HRT","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"HRT: conjugated estrogen 0.625 mg/day plus medroxyprogesterone 2.5 mg/day","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
25,1,"Treatment versus reference, secondary","Etidronate 400 mg/day versus intermittent/cyclic clodronate","SUBGROUP_AND_OVERALL","Russo 1996",1996,0,0,0,0,0,31,0,0,0,8,0,0,NA,NA,NA,NA,"Intermittent/cyclic clodronate: repeated cycles of (20-day clodronate 100 mg/day, IM→ 10-day break→ 2-month oral clodronate 400 mg/day→ 1-month break).","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
25,1,"Treatment versus reference, secondary","Etidronate 200 mg/day versus calcitonin 20 IU/week, IV","SUBGROUP_AND_OVERALL","Ishida 2004",NA,0,0,0,0,0,66,0,0,0,66,0,0,NA,NA,NA,NA,"","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003376.pub4/full","10.1002/14651858.CD003376.pub4","1::overall","CD003376_pub4_data","direction_only",FALSE,FALSE,FALSE,-0.0979532814479582,0.00518956749416327,-0.303986864444109,0.108080301548193,-0.00265554806460928,0.0130346830529358,TRUE,TRUE
